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Espen E. Spangenburg,5 Michael Kyba,2 and Dawn A. Lowe1,8,*
1Divisions of Rehabilitation Science and Physical Therapy, Department of Rehabilitation Medicine, Medical School, University of Minnesota,
Minneapolis, MN, USA
2Lillehei Heart Institute and Department of Pediatrics, Medical School, University of Minnesota, Minneapolis, MN, USA
3Department of Integrative Biology and Physiology, Medical School, University of Minnesota, Minneapolis, MN, USA
4Gerontology Research Center, Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland
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Skeletal muscle mass, strength, and regenerative
capacity decline with age, with many measures
showing a greater deterioration in females around
the time estrogen levels decrease at menopause.
Here, we show that estrogen deficiency severely
compromises the maintenance of muscle stem cells
(i.e., satellite cells) as well as impairs self-renewal
and differentiation into muscle fibers. Mechanisti-
cally, by hormone replacement, use of a selective
estrogen-receptor modulator (bazedoxifene), and
conditional estrogen receptor knockout, we implicate
17b-estradiol and satellite cell expression of estrogen
receptor a and show that estrogen signaling through
this receptor is necessary to prevent apoptosis of
satellite cells. Early data from a biopsy study of
women who transitioned from peri- to post-meno-
pause are consistent with the loss of satellite cells
coincident with the decline in estradiol in humans.
Together, these results demonstrate an important
role for estrogen in satellite cell maintenance and
muscle regeneration in females.
INTRODUCTION
Over the course of an individual’s life, skeletal muscle un-
dergoes numerous injurious insults that require repairs in order
for function to be maintained. The maintenance and injury repair
of skeletal muscle is dependent on its resident stem cell
(i.e., the satellite cell), with genetic ablation of satellite cells
completely abolishing the ability of skeletal muscle to regen-
erate following injury (Fry et al., 2015; Murphy et al., 2011; Sam-
basivan et al., 2011). Satellite cells are located between the
sarcolemma and the basal lamina of skeletal muscle fibers,
where they remain in a quiescent state (Conboy and Rando,368 Cell Reports 28, 368–381, July 9, 2019 ª 2019 The Author(s).
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2007), becoming activated through external stimuli, such as a
muscle injury, initiating the transition from quiescence into the
myogenic program to repair damaged muscle (Conboy and
Rando, 2002; Dumont et al., 2015; Hindi and Kumar, 2016;
Kuang et al., 2007; Troy et al., 2012). With proliferation, satellite
cells undergo asymmetric division through which a subpopula-
tion of the daughter satellite cells do not differentiate, but
instead return to quiescence, repopulating the satellite cell
pool (i.e., self-renewal) (Kuang et al., 2007; Troy et al., 2012).
The balance of this asymmetric division process is critical and
necessary to ensure the life-long preservation of satellite cells
in skeletal muscle.
Aging diminishes the satellite cell pool (Keefe et al., 2015;
Sajko et al., 2004; Verdijk et al., 2014) and, as a result, the
regenerative capacity of skeletal muscle in aged males is
impaired compared to that of younger males (Brack et al.,
2005; Carlson and Conboy, 2007; Chakkalakal et al., 2012;
Keefe et al., 2015; Shefer et al., 2006), but such age-induced
impairments in females is less studied. Similarly, age-associ-
ated changes in the satellite cell environment, in combination
with cell-intrinsic alterations, disrupt quiescence and the bal-
ance of asymmetric division, ultimately impacting satellite cell
maintenance and muscle regenerative potential (Bernet et al.,
2014; Conboy et al., 2005; Cosgrove et al., 2014; Sousa-Victor
et al., 2014). Such results support the concept that circulatory
factors, including hormones that differ between the young and
old systemic environments and the activity of their subsequent
signaling pathways, contribute to age-associated decrements
in satellite cell maintenance and overall muscle regenerative
capacity.
A well-known hormone that changes with age is estradiol, the
main circulating sex hormone in adult females. Estradiol is not
only a major regulator of gonadal organ development and func-
tion, but it is also now recognized for its protective effects in
other tissues (e.g., against cardiovascular disease and osteopo-
rosis) in women prior to the menopausal transition (Deschamps
et al., 2010). Serum estradiol concentration declines dramaticallycreativecommons.org/licenses/by-nc-nd/4.0/).
at the average age of 51 in women, corresponding to the time of
menopause (Baber et al., 2016). Estradiol deficiency reduces
skeletal muscle mass and force generation in women (Greising
et al., 2009; Phillips et al., 1993, 1996; Qaisar et al., 2013; Taaffe
et al., 2005) and female rodents (Greising et al., 2011;
Moran et al., 2007) and prevents the recovery of strength
following contraction-induced muscle injury (Kosir et al., 2015;
Rader and Faulkner, 2006) and traumatic muscle injury in female
mice (Le et al., 2018). However, evidence that this regenerative
phenotype involves effects of estradiol directly on satellite cells
is lacking. For example, the estrogen requirement for muscle
regeneration has previously been based simply on a lower
mass, cross-sectional area, and a fibrosis index of a single mus-
cle at a single time point (14 d) following a single type of injury
with no changes in satellite cell number (Kitajima and Ono,
2016). Previous work has also indicated that exercise-induced
activation of satellite cells is less effective in the absence of
estradiol (Enns and Tiidus, 2008) and that androgens contribute
to the regulation of juvenile satellite cells during growth (Kim
et al., 2016), but it has yet to be determined if there are cell-
autonomous (receptor- or non-receptor-mediated) mechanisms
that involve estradiol acting directly on satellite cells.
In this study, we use rigorous and unbiased approaches
(e.g., two independent sets of markers to quantify satellite
cell numbers from entire muscles by flow cytometry, in five
different muscles, at three time points of estrogen deficiency,
as well as by an independent method immunohistochemistry,
plus reversal of the phenotype by treating mice with estradiol
and measurements of self-renewal and differentiation by trans-
plantation) to demonstrate the in vivo necessity of estradiol to
maintain the satellite cell number in females. Further, we use
mouse genetics to show that the molecular mechanism of
estradiol action is cell-autonomous signaling through estrogen
receptor a (ERa). Specifically, we show the functional conse-
quence of estradiol-ERa ablated signaling in satellite cells
including impaired self-renewal, engraftment, and muscle
regeneration, and the activation of satellite cell mitochondrial
caspase-dependent apoptosis.
RESULTS
Estradiol Regulates Satellite Cell Maintenance
To directly test whether ovarian hormone deficiency affects the
satellite cell compartment, we counted the total number of satel-
lite cells in five diverse muscles from control and ovariectomized
(Ovx) mice (Figure S1). Satellite cells (lineage negative; vascular
cell adhesion protein [VCAM], alpha7 double positive) were
30%–60% fewer in number in tibialis anterior (TA) muscles of
Ovx than control mice, and reduction was associated with the
duration of hormone deficiency (Figure 1A). Extensor digitorum
longus (EDL), gastrocnemius, and diaphragms in Ovx mice had
reduced satellite cell numbers as well (Figure 1A). The soleus,
which is a slower and more fatigue-resistant muscle, was unaf-
fected by hormone manipulation (Figure 1A). We also evaluated
the density of satellite cells, calculated by dividing the cell num-
ber (Figure 1A) by the wet mass of each muscle (Figures 1B and
1C). Satellite cell density recapitulated the cell number declines
with ovarian hormone deficiency in the TA, gastrocnemius, andEDL muscles. In the diaphragm, where the decline in total num-
ber was only statistically significant at the 2-month point, the
decline in satellite cell density was statistically significant at all
time points studied (Figure 1C).
To confirm the effect of ovarian hormone deficiency on the sat-
ellite cell number using an independent marker, we employed
the Pax7-ZsGreen mouse model, in which quiescent satellite
cells fluoresce green, and differentiating cells rapidly lose fluo-
rescence (Bosnakovski et al., 2008). Consistent with results
from surface marker staining, ZsGreen+ cells were significantly
lower in the TA, EDL, and gastrocnemius muscles of 2-month
hormone-deficient Ovx mice compared to control, with the dia-
phragm trending and soleus again being less affected (Fig-
ure S2). We also counted the Pax7+ cells in immuno-stained
TAmuscle sections to independently verify the results of fluores-
cence-activated cell sorting (FACS) quantification (Figure 1D).
Histological analysis showed that TA muscles from Ovx mice
have 50% fewer satellite cells than controls (Figure 1E).
Ovariectomy results in systemic changes and deficiencies of
multiple hormones. To determine if estradiol was the hormone
responsible for affecting satellite cells, a subset of Ovx mice
was treated with 17b-estradiol simultaneously with Ovx. Treat-
ment with this specific ovarian hormone rescued satellite cell
numbers, preventing depletion of the satellite cell pool (Figures
2A–2D), thus demonstrating sufficiency for the hormone
estradiol.
Given that the loss of estradiol perturbs maintenance of the
satellite cell pool during homeostatic conditions, we aimed to
determine if this loss of satellite cell number resulted in functional
consequences. We investigated if recovery of function (i.e.,
strength) from a chemical injury to the TA muscle was affected
by the loss of estradiol (Ovx+Placebo). Following a single bout
of injury, estradiol deficiency did not affect strength recovery un-
til 21 days post-injury, which resulted in a 19% lower torque
strength (p = 0.06; Figure 2E). Strikingly, following a second
bout of injury, strength recovery was substantially lower by
23%–39% at the three time points: 28, 35, and 42 days post-
injury. Treatment with estradiol (Ovx+E2) rescued the decre-
ments in strength (p % 0.019; Figure 2E). These results demon-
strate that the decline in satellite cell number is associated with
an impaired regenerative response.
Estradiol Deficiency Impairs Self-Renewal and
Differentiation In Vivo
The disruption of satellite cell maintenance and the impairment in
strength recovery following injury that occurred with the loss of
estradiol led us to next determine if self-renewal and/or differen-
tiation were affected, as these cellular processes have direct
implications for the replenishment of the satellite cell pool. We
assayed self-renewal and differentiation in vivo via transplanta-
tion. Satellite cells were harvested from bulk hindlimb cell prep-
arations from female Pax7-ZsGreen mice, and 600 cells were
transplanted into previously irradiated, cardiotoxin-injured TA
muscles of control or Ovx recipient syngeneic C57/BL6J mice
(Figure 3A). Satellite cell engraftment was measured by FACS
using the donor ZsGreen+ marker, which is maintained only in
the undifferentiated Pax7+ donor-derived satellite (Figure 3B).
Estradiol deficiency of the recipient resulted in 75% lowerCell Reports 28, 368–381, July 9, 2019 369
Figure 1. Estrogen Deficiency Disrupts Maintenance of Satellite Cells in Skeletal Muscles of Females
(A) Total number of satellite cells quantified by lineage negative;VCAM,alpha7 double-positive cells in five discrete muscles from control (n = 15) and ovariec-
tomized (Ovx; n = 15) mice. Muscles were harvested and analyzed 2, 4, or 7 months after Ovx and in age-matched controls.
(B) Muscle masses.
(C) Total number of satellite cells normalized to muscle masses.
(D) Satellite cells quantified by immunohistochemistry of Pax7+ cells in TA muscles from control (n = 4) and Ovx (n = 4) mice at 2 months of hormone deficiency.
Arrows indicate localization of DAPI+ Pax7+double-positive cell. Scale bars, 50 mm.
(E) TAmuscle cross-sectional area and number of fibers from control andOvxmice (pR 0.193), and Pax7+ cells per TAmuscle cross-sectional area and%Pax7+
cells in each cross section relative to the total number of muscle fibers.
Significantmain effects of two-way ANOVA (p < 0.05) are indicated above the bars (A–C) andwhen interactions occurred (p < 0.05), Holm-Sidak post hoc tests are
indicated by the following symbols: *, different than control at corresponding duration (A–C); f, different than 2- and 4-month Ovx (A and C); and +, different than
2- and 7-month Ovx (B). **p < 0.005 by Student’s t tests (E).engraftment of the satellite cell compartment compared to con-
trol recipients (Figure 3C).
To address the contribution of satellite cells to fibers, we uti-
lized a lineage-tracing strategy (Pax7 CreERT2/+; R26RtdTom
mice) to mark donor-derived fibers (Figure 3D). This experiment
again confirmed the deleterious effect of systemic estradiol defi-
ciency on satellite cell engraftment (Figures 3E and 3F) and
further demonstrated that while satellite cells contributed
robustly to fibers in the muscle of control recipients, contribution370 Cell Reports 28, 368–381, July 9, 2019to fibers wasminimal when estradiol was not present (Figures 3G
and 3H). As a result of the reduced engraftment and differentia-
tion potential of the satellite cells when transplanted from an
estradiol-replete environment into one lacking estradiol, we
next aimed to determine if satellite cells from an environment
lacking estradiol (i.e., from Ovx donors) were intrinsically, irre-
versibly impaired, or whether they would be functional in an
estrogen-replete environment. ZsGreen+ satellite cells were iso-
lated from the TA and gastrocnemiusmuscles of control andOvx
Figure 2. Estradiol Maintains the Satellite
Cell Pool and Accelerates Recovery of
Strength
(A) Representative FACS plots of cells isolated
from TA muscles of Ovx mice without (n = 3) and
with 17b-estradiol treatment (Ovx+E2; n = 4).
(B) Total number of satellite cells.
(C) TA muscle mass.
(D) Total number of satellite cells relative to TA
muscle mass.
(E) Maximal isometric torque (i.e., strength) ex-
pressed relative to pre-injury torque in Ovx mice
without (Ovx+Placebo; n = 6) or with 17b-estradiol
treatment (Ovx+E2; n = 8) following repeated in-
juries to TA muscle.
*p < 0.05 and **p < 0.005 by Student’s t tests (A–D)
and Holm-Sidak post hoc (E).donor mice, and 600 cells were transplanted into control recipi-
ents (Figure 3I). The transfer into an estradiol-replete environ-
ment (i.e., control recipient) rendered satellite cells from Ovx
mice similar to those of controls (Figures 3J and 3K).
In Humans, Satellite Cell Number Declines during the
Menopausal Transition
Satellite cell number declines with age in humans; however,
the majority of studies have compared muscle from old men
(70 year old) to young men (20 year old), and the studies
have been cross-sectional in design (Verdijk et al., 2012,
2014). To date, satellite cell number has not been evaluated dur-
ing the menopausal transition in women, nor to our knowledge
have any aging longitudinal studies of satellite cell numbersbeen conducted in humans. Here, we
aimed to determine if the satellite cell
number declines during the peri- to
post- menopausal transition in women
by taking two muscle biopsies from the
same women at peri- and post-meno-
pause and staining these for Pax7 (Fig-
ures 4A and 4B). Satellite cell number
declined 15% on average during the tran-
sition and trended very close to statistical
significance (p = 0.057; Figure 4C), and
declines were observed in four out of
the five women (Figure 4D). This reduc-
tion is striking since the peri- to post-
menopause transition in these women
occurred within a 1-year time period,
and the cell number declines cannot be
attributed to reduced physical activity or
myofiber size (Figure 4A). We observed
that not all study participants displayed
the same degree of estradiol loss across
the time in which longitudinal biopsies
were obtained. Thus, we performed a
Pearson correlation between serum con-
centration of estradiol and satellite cells in
peri- and post-menopausal samples fromthe same five women (Figure 4E). The result is a strong correla-
tion that met statistical significance (r2 = 0.478 p = 0.023; Fig-
ure 4F), indicating that even with the low sample size not
yet allowing the acceptance of the hypothesis of a sudden sat-
ellite cell decline at the peri-to-post-menopausal transition, the
data support that changes in the satellite cell number across this
transition are related to changes in 17b-estradiol concentration.
ERa Is the Relevant ER in Satellite Cells
There are three known ERs in skeletal muscle: ERa, ER beta
(ERb), and g-protein coupled ER (GPER). We have recently
established that the effects of estradiol on force generation by
skeletal muscle are mediated by ERa (Collins et al., 2018). This
result, in combination with other work showing ERa is involvedCell Reports 28, 368–381, July 9, 2019 371
Figure 3. Loss of Estradiol in the Environment Negatively Affects Satellite Cell and Fiber Engraftment That Can be Rescued by the Presence
of Estradiol
(A) Transplantation scheme for ZsGreen+ cells transplanted into control and Ovx recipients.
(B) Representative FACS plots of ZsGreen+ donor satellite cells in TA muscle 1 month post-transplant in control and Ovx recipient mice.
(C) Total number of ZsGreen+ donor satellite cells in control (n = 12) and Ovx (n = 15) recipient mice 1 month post-transplant.
(D) Scheme for tdTom+ cells transplanted into control (n = 6) and Ovx (n = 6) recipients.
(E) Representative FACS plots of tdTomato red fluorescent protein (tdTOM)+ donor satellite cells in TA muscle 1 month post-transplant in control and Ovx
recipient mice.
(F) Total number of tdTOM+ donor satellite cells in control (n = 6) and Ovx (n = 6) recipient mice 1 month post-transplant.
(G) Representative images of tdTom+ fibers in the engrafted region of TA muscle from control and Ovx recipient mice. Scale bars, 100 mm.
(H) Quantification of total number of tdTom+ fibers from control and Ovx recipients.
(I) Transplantation scheme for ZsGreen+ cells from control and Ovx donors.
(J) Representative FACS plots of ZsGreen+ control and Ovx donor satellite cells in TA muscle 1 month following transplant in control recipient mice.
(K) Total number of ZsGreen+ control (n = 8) and Ovx (n = 6) donor satellite cells in control recipient TA muscles 1 month post-transplantation.
*p < 0.05 and **p < 0.005 by Student’s t tests.in regulating muscle metabolism (Hamilton et al., 2016; Ribas
et al., 2016; Ronda et al., 2013) and oxidative stress (Baltgalvis
et al., 2010; Vasconsuelo et al., 2008), led us to determine the372 Cell Reports 28, 368–381, July 9, 2019following: (1) whether satellite cells express female sex hormone
receptors; (2) which ER is most highly expressed in satellite cells;
and (3) whether this receptor was essential in mediating the
Figure 4. Peri- to Post-Menopausal Transition Results in Decline of Muscle Satellite Cells in Humans
(A) Subject characteristics of women participants (n = 5).
(B) Representative images of DAPI stained nuclei (blue), Pax7 satellite cells (gold), and merged images from cross sections of muscle biopsies from peri-
menopausal women and of the same women when post-menopausal status was reached. Scale bars, 50 mm.
(C) Quantification of percentage of Pax7+ cells counted in each cross section relative to the total number of fibers in muscle biopsies from peri-menopausal and
post-menopausal women (p = 0.057).
(D) Declines in the percentage of Pax7+ cells in muscle cross sections of four out of five individual women during the two menopausal stages.
(E) Individual serum estradiol (E2) levels in women during the two menopausal stages.
(F) Pearson correlation between E2 and%Pax7+ cells (p = 0.023). Peri-menopausal women shown in closed circles and post-menopausal women shown in open
circles (def).activity of estradiol on satellite cell function. RNA sequencing
(RNA-seq) and qRT-PCR on sorted Pax7-ZsGreen+ cells (Fig-
ure 5A) showed that satellite cells express Esr1, the gene encod-
ing ERa, significantly more than the other two ERs, Esr2 (ERb)
and Gper1, and the progesterone receptor, Pgr (Figure 5B). To
this point, Esr2, Gper1, and Pgr had transcript per kilobase
million (TPM) expression values less than 1 (Figure 5B), and
Esr2 was undetectable in our qRT-PCR analysis. Esr1 was also
more highly expressed in ZsGreen+ cells compared to other
mononuclear cells (ZsGreen cells) (Figure 5C). Therefore, we
developed an inducible satellite cell-specific ERa knockout
model (Figures 5D–5F) in order to specifically probe the neces-
sity of ERa in themechanism by which estradiol mediates effectson satellite cells. The genetic deletion of ERa did not result in the
compensation of the other hormone receptors in satellite cells
(Figures 5D–5F).
Estradiol Signals Cell Autonomously to Maintain
Satellite Cell Number
We treated Pax7CreERT2/+; Esr1fl/fl;Pax7-ZsGreen female mice
(scERaKO) and Pax7+/+;Esr1fl/fl;Pax7-ZsGreen control sibling
females (scERaWT) with tamoxifen to ablate ERa and evaluate
satellite cell frequency in multiple muscle groups by FACS (Fig-
ure S3). Ablation of ERa in satellite cells resulted in 40%–60%
fewer satellite cells in all five muscles analyzed; again, both
expressed in terms of absolute cell numbers and satellite cellCell Reports 28, 368–381, July 9, 2019 373
Figure 5. Estrogen Receptor Alpha (ERa) Is the Relevant Hormone Receptor in Satellite Cells
(A) mRNA gene expression of Pax7 in isolated ZsGreen+ satellite cells from Pax7-ZsGreen female mice (n = 4).
(B) Transcripts per kilobase million (TPM) of ER alpha (Esr1), ER beta (Esr2), g-protein coupled ER (Gper1), and progesterone receptor (Pgr) in isolated ZsGreen+
satellite cells from Pax7-ZsGreen mice (n = 3).
(C) mRNA gene expression of Esr1 ZsGreen mononuclear cells and Zsgreen+ satellite cells from Pax7-ZsGreen mice (n = 4)
(D) TPM of Esr1, Esr2, Gper1, and Pgr in Pax7+/+;Esr1fl/fl;Pax7-ZsGreen (scERaWT; n = 3) and Pax7CreERT2/+;Esr1fl/fl;Pax7-ZsGreen (scERaKO; n = 3) mice.
(E and F) mRNA gene expression of Esr1 and Gper1 (E) relative to Esr1 expression and (F) relative to that in scERaWT in isolated ZsGreen+ satellite cells from
scERaWT (n = 3) and scERaKO (n = 4) mice.
ANOVA, Holm-Sidak post hoc tests indicated by **p < 0.005, significantly different from Esr1 (B) or scERaWT (D–F)density (i.e., normalized to muscle mass) (Figures 6A–6C). We
replicated these results by performing Pax7 immuno-staining
of TA muscle cross sections from scERaWT and scERaKO
female mice (Figure S3). The magnitude of the satellite cell
reductions was similar to those of the estradiol deficiency
(compare Figures 6A–6C with Figures 1A–1C). Furthermore,
the removal of ovarian hormones (scERaKO+Ovx) and the treat-
ment of estradiol (scERaKO+Ovx+E2) in scERaKO mice did not
result in a further decline or a rescue of the satellite cell number,
respectively (Figures 6D–6F). These results mechanistically
show that ERa is required for estradiol signaling to maintain
the satellite cell pool in muscles of females.
It was not known whether the new selective ER modulator,
bazedoxifine (BZA), would be an ER agonist or antagonist in
skeletal muscle. We show that Ovx mice treated with BZA374 Cell Reports 28, 368–381, July 9, 2019rescued the detrimental effects on satellite cell number (p =
0.055; Figure 6G), demonstrating that it is an agonist in muscle.
Because BZA functions by binding ERs, this result further sup-
ports the concept that estradiol’s mechanism of action in satel-
lite cells is receptor mediated.
ERa Is Necessary for Satellite Cell Self-Renewal
We next tested whether the loss of ERa in satellite cells would
impair self-renewal using the in vivo transplantation assay, similar
to what was measured with estradiol deficiency (Figure 6H). 600
ZsGreen+ satellite cells from female scERaWT and scERaKO
mice were transplanted into control C57/BL6J recipient mice,
and the contribution to the satellite cell compartment was
measured by FACS analysis of total recipient muscle 1 month
post-transplant (Figures 6H and 6I). Analogous to the Ovx study,
Figure 6. Estradiol Regulates Satellite Cell Number Cell Autonomously through ERa
(A) Total number of ZsGreen+ satellite cells in five muscles of Pax7+/+;Esr1fl/fl;Pax7-ZsGreen (scERaWT; n = 6) and Pax7CreERT2/+;Esr1fl/fl;Pax7-ZsGreen
(scERaKO; n = 6) mice.
(B) Muscle masses.
(C) Total number of ZsGreen+ cells normalized to muscle mass.
(D) Total number of satellite cells quantified by lineage negative;VCAM,alpha7 double-positive cells in two muscles of scERaWT (n = 6), scERaKO (n = 4),
scERaKO+Ovx (n = 5), and scERaKO+Ovx+17b-estradiol (scERaKO+Ovx+E2; n = 5).
(E) Muscle masses.
(F) Total number of satellite cells normalized to muscle masses.
(G) Total number of satellite cells isolated from TA muscles of Ovx mice without (n = 6) and with Bazedoxifine (Ovx+BZA; n = 5) treatment (p = 0.055).
(H) scERaWT and scERaKO transplantation scheme.
(I) Quantification of ZsGreen+ donor satellite cells in control recipient TA muscles following transplantation.
*p < 0.05 by Student’s t tests (A–C, G, and I) *p < 0.05 ANOVA, Holm-Sidak post hoc tests are indicated by *, different from scERaWT (D–F)we observed a dramatic reduction in satellite cell engraftment in
the absence of ERa in donor satellite cells (Figure 6I), supporting
the interpretation that ERa is the relevant ER maintaining homeo-
static control of self-renewal in response to estradiol.Apoptosis of Satellite Cells with Estradiol Deficiency
Wenext investigated whether themechanism for the reduction in
the cell number and impaired self-renewal could involve
apoptosis. In non-skeletal muscle tissues, estradiol is known toCell Reports 28, 368–381, July 9, 2019 375
protect against apoptosis (e.g., Guo et al., 2013; Zhou et al.,
2018), and immortalized myoblasts were also found to undergo
less apoptosis in vitro in the presence of estradiol (Boland
et al., 2008; La Colla et al., 2017; Vasconsuelo et al., 2010). It
has been suggested that apoptosis plays an important role in
skeletal muscle health, ultimately affecting strength (La Colla
et al., 2015; Pallafacchina et al., 2013; Sanchez et al., 2014).
However, it is important to point out that in healthy unperturbed
muscle, apoptotic cells are from other lineages, and rates of
apoptosis of quiescent satellite cells during homeostatic condi-
tions are nearly zero (Fry et al., 2016; Hirai et al., 2010; Shea
et al., 2010). First, wemeasured overall apoptosis in vivo by iden-
tifying terminal deoxynucleotidyl transferase (TdT) dUTP nick-
end labeling (TUNEL)+ cells in the TA muscles of control, Ovx,
and Ovx+E2 mice (Figures S4A and S4B). Muscle from all groups
of mice contained apoptotic cells, with estradiol-deficient mus-
cles having 3.7-fold more TUNEL+ cells compared to controls.
(Figure S4B). Furthermore, estradiol treatment (Ovx+E2) was
able to rescue this detrimental effect by protecting cells from
apoptosis (Figure S4B).
To determine whether any of these newly induced apoptotic
cells were actually satellite cells, we counterstained samples
with Pax7. Loss of estradiol resulted in 2% of the Pax7 popula-
tion being apoptotic (i.e., Pax7+TUNEL+ cells), while in controls
and estradiol treated, the frequency was close to zero (0.03%
and 0.0%, respectively; Figure 7A). To validate these results
from the level of transcription, we then isolated Pax7-ZsGreen+
cells from control and Ovx mice and evaluated the transcription
of apoptosis-related genes. Estradiol deficiency resulted in 3- to
1500-fold upregulation of p53, p38, Becn1, and Casp3 gene
expression (Figure 7B).
To investigate more deeply the mechanism by which estradiol
signaling through ERa maintains satellite cell number and facili-
tates self-renewal, we performed RNA-seq and compared the
transcriptome of ZsGreen+ satellite cells from female scERaWT
and scERaKO mice (Figure S4C). Globally, principal component
analysis (PCA) revealed patterns of genes that are changed with
the loss of ERa (Figure 7C) with TPM >5 and 388 genes being
differentially expressed between scERaWT and scERaKO satel-
lite cells (Figure 7D). Thiswascorroboratedby thedownregulation
of classical ERa target genes (Figure 7E). To explore the pathways
that were cell-autonomously regulated by ERa, we performed in-
genuity pathway analysis (IPA) (Figure S4D), with the top pathway
of this analysis being cell death and survival (Figures 7F andS4D).
Compared to scERaWT, scERaKO satellite cells exhibited upre-
gulation of genes promoting cell death (e.g., H19, Fndc1, and
mir378c) and downregulation of genes promoting cell survival
(e.g., Dhcr24, Snord65, and mir485; Figure 7G). To validate this
result, we completed qRT-PCR on top hits in the IPA in addition
to top apoptotic-related hits in the 388 differentially expressed
gene analysis (Figure 7H). To summarize, estradiol and ERa pro-
mote satellite cell survival via downregulation of genes associated
with mitochondrial caspase-induced apoptosis.
DISCUSSION
The notion that age-associated deficits in skeletal muscle can be
driven by extrinsic factors that differ between young and aged376 Cell Reports 28, 368–381, July 9, 2019environments is well established by heterochronic parabiosis ex-
periments (Brack et al., 2007; Conboy et al., 2005). Estradiol is a
particularly interesting hormone in this regard, as its levels are
much higher in females than in males (Nelson and Bulun,
2001); levels fall precipitously in females at the menopausal tran-
sition (Baber et al., 2016), and hormone therapy has been found
to have beneficial effects on skeletal muscle health in post-
menopausal women (Phillips et al., 1993; Qaisar et al., 2013).
To date, actions of estradiol on skeletal muscle have focused pri-
marily on protein synthesis (Kamanga-Sollo et al., 2010; Toth
et al., 2001), inflammation (Le et al., 2018; McClung et al.,
2007; Ribas et al., 2010), and force generation (Collins et al.,
2018; Lai et al., 2016; Moran et al., 2007). The results presented
here show that estradiol is necessary for satellite cell mainte-
nance and function in females. When estradiol is lacking in the
systemic environment, the number of satellite cells is reduced
by 30%–50% in four of five skeletal muscles studied. This result
is in contrast to previous studies that did not detect a loss of sat-
ellite cell number with estrogen deficiency (Enns et al., 2008; Ki-
tajima et al., 2015; Kitajima and Ono, 2016; Thomas et al., 2010),
perhaps due to less-sensitive approaches than what was used
here. Further, we show that the consequence of the estradiol-
deficient mediated loss of satellite cells is blunted recovery of
strength following injury. Strength recovery from injury is exacer-
bated by a second bout of injury, suggesting that satellite cell
self-renewal or differentiation is impaired.
To this point, satellite cells harvested from an estradiol-rich
environment failed to populate the satellite cell compartment
when transplanted into a host environment that lacked estradiol,
but when satellite cells from the pool remaining in a hormone-
deficient environment were transplanted into a host environment
with estradiol, engraftment, self-renewal, and differentiation
were robust. Moreover, wemeasured a similar decline in satellite
cell pool size when ERa was deleted, specifically from satellite
cells in steady-state muscle regardless of whether or not estra-
diol was in the environment. These results strongly suggest a
cell-autonomous role for estradiol signaling through a recep-
tor-mediated mechanism via ERa in the satellite cell itself, the
impairment of which leads to a reduction in satellite cell pool size.
In principal, a reduction in stem cell pool size can be explained
by three possible mechanisms: differentiation, death, or emigra-
tion of cells from the tissue. We find no evidence of increased
differentiation in the estradiol-deficient environment. Rather,
the opposite appears to hold: when lineage-marked cells were
transplanted, there was a greater contribution to differentiated
muscle fibers in the estradiol-replete environment than in the
deficient environment. Given that an impairment in differentiation
would tend to increase the number of stem cells, not decrease it,
we feel that the lack of contribution to differentiated muscle in
this assay is not due to a differentiation blockade. Rather,
because we find a subpopulation of Pax7+ cells that are
TUNEL+, together with a very strong apoptotic transcriptional
response, it is most likely that Pax7+ cells are being lost to
apoptosis. Estradiol is known for anti-apoptotic effects in
some other contexts: for example, studies on C2C12 cells pro-
vide evidence that estradiol can be protective from H2O2-
induced apoptosis through modulating P53 and forkhead box
transcription factor class O (FOXO) transcription factors and
Figure 7. Loss of ERa Results in Satellite Cell Apoptosis
(A) Percent of Pax7+ cells that were also TUNEL+ in cross sections of TAmuscles from control (n = 4) andOvxwithout (Ovx; n = 4) andwith 17b-estradiol treatment
(Ovx+E2; n = 3).
(B) qRT-PCRmRNA expression of apoptosis-related genes in ZsGreen+ satellite cells isolated from gastrocnemiusmuscles of control (n = 4) andOvxmice (n = 4).
(C) Principal component analysis (PCA) of RNA-seq profiles of ZsGreen+ satellite cells of Pax7+/+;Esr1fl/fl;Pax7-ZsGreen (scERaWT; n = 3) and Pax7CreERT2/+;
Esr1fl/fl;Pax7-ZsGreen (scERaKO; n = 3) mice.
(D) Heatmap of 388 differentially expressed genes in satellite cells of scERaWT and scERaKO mice.
(E) Transcripts per kilobase million (TPM) of ERa target genes, nuclear receptor interaction protein (Nrip), growth regulating ER binding 1 (Greb1), and oxytocin
receptor (Oxtr).
(F) Top 10 molecular and cellular functions from ingenuity pathway analysis (IPA). Red box to highlight the top pathway, cell death, and survival.
(G) Top 10 upregulated and top 10 downregulated apoptosis-related genes from IPA in satellite cells of scERaWT and scERaKO mice.
(H) qRT-PCR mRNA expression of apoptosis-related genes in ZsGreen+ satellite cells of scERaWT and scERaKO mice.
Significance tested with ANOVA, Holm–Sidak post hoc tests are indicated by *, different from control and Ovx+E2, *p < 0.05 (A) and *p < 0.05 and **p < 0.005 by
Student’s t tests (B, E, and G).their downstream target genes (Boland et al., 2008; La Colla
et al., 2017). In pancreatic cells, estradiol is known to signal
through a receptor-mediated mechanism to protect againstmitochondrial-induced apoptosis (Zhou et al., 2018). Concerning
the third possibility, although our studies do not formally rule out
emigration of satellite cells from estradiol-deficient muscle, theCell Reports 28, 368–381, July 9, 2019 377
scenario seems unlikely because satellite cells do not repopulate
via the circulation into muscles that have been completely
depleted by freeze injury (although they can migrate into adja-
cent muscles if connective tissues are disrupted; Schultz et al.,
1986).
Hormone therapy is controversial because of the small but
detectable increase in breast cancer risk (Kim et al., 2018). The
etiology of this disease is thought to be related to estradiol stim-
ulation or mutations in the gene ERa (Dall et al., 2018; Gelsomino
et al., 2018; Severson et al., 2018), which is known to exert
proliferation of the normal breast tissue (Dall et al., 2018). How-
ever, pharmacological progress has been made, and there
now exists US Food and Drug Administration (FDA)-approved
selective ER modulators (SERMs) (Börjesson et al., 2016).
Because SERMs function by inducing conformational changes
in ER resulting in tissue-specific agonistic or antagonistic ef-
fects, largely depending on which cofactors are present, it was
not clear whether the SERM, BZA, would present as an agonist
or antagonist in skeletal muscle (Beck et al., 2015; Börjesson
et al., 2016). Our results suggest that BZA is an ER agonist in
skeletal muscle, or at least in muscle stem cells, as it restored
the satellite cell pool in estradiol-deficient mice. This result, along
with our finding that ERa is the relevant receptor whose signaling
is necessary to maintain the satellite cell pool, supports the use
of ERa-selective ligands for therapeutic application in meno-
pause-associated muscle loss.
Notably, we also present preliminary data from a longitudinal
biopsy study of aging skeletal muscle. This study tracks muscle
in women and employs variable biopsy dates. The first biopsy is
at peri-menopause, and the second is at post-menopause, with
timing being unique to each participant and determined by
changes in their estradiol and follicle stimulating hormone levels.
The time between the first and second biopsies was short (1
year). Accordingly, although we observed a reduction in the
mean satellite cell number from the first biopsy to the second,
we observed a much greater significance in the correlative anal-
ysis between changes in estradiol levels with satellite numbers;
this comparison is actually themost relevant to the current study.
In summary, our results demonstrate that estradiol is a neces-
sary factor regulating in vivo satellite cell function in female
rodents and is supported by similar results in humans. The estra-
diol-ERa axis contains potential therapeutic targets to mitigate
skeletal muscle deficits observed with aging in women. Our
study provides a scientific basis for future studies to examine
ER agonists, such as BZA, more thoroughly to probe for addi-
tional benefits toward overall musculoskeletal health in post-
menopausal women. Finally, these collective results highlight
the importance of considering biological sex and sex hormones
when studying skeletal muscle, particularly regarding age-
related deficits in muscle.STAR+METHODS
Detailed methods are provided in the online version of this paper
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
PE-Cy7 rat anti-mouse CD31 (clone 390) BD Biosciences Cat# 561410 ; RRID:AB_10612003
PE-Cy7 rat anti-mouse CD45 (clone 30-F11) BD Biosciences Cat# 552848 ; RRID:AB_394489
Biotin rat anti-mouse CD106 (clone 429(MVCAM.A) BD Biosciences Cat# 553331; RRID:AB_394787
PE Streptavidin BD Biosciences Cat# 554061; RRID:AB_10053328
Itga7 647 (clone R2F2) AbLab Cat# AB000000274
Anti-Pax7 mouse IgG1 DSHB Cat# PAX7
Gt anti-mouse biotin-conjugated secondary Jackson Immuno Research
Laboratories
Cat# 115-065-205 ; RRID:AB_2338571
Anti-laminin rabbit Sigma-Aldrich Cat# L9393 ; RRID:AB_477163
Gt anti-rabbit Alexa 488 secondary Life Technologies Cat# A11034 ; RRID:AB_2576217
Anti-RFP rabbit polyclonal Rockland Immunochemicals Inc Cat# 600-401-379 ; RRID:AB_2209751
Anti-laminin mouse Sigma-Aldrich Cat# Clone LAM-89 ; RRID:AB_477162
Gt anti-mouse Alexa 555 Life Technologies Cat# A-21422 ; RRID:AB_2535844
Chemicals, Peptides, and Recombinant Proteins
Collagenase Type II GIBCO Cat# 17101-015
Dulbecco’s modified Eagle’s medium (DMEM) without phenol
red containing 4.00 mM L-glutamine, 4,500 mg/L glucose,
and sodium pyruvate
Hyclone Cat# SH30284.01
Ham’s/F-10 Media Hyclone Cat# SH30025.01
Horse Serum GIBCO Cat# 26050088
HEPES Buffer GIBCO Cat# 15630080
Pen/Strep GIBCO Cat# 15140122
Dispase GIBCO Cat# 17105-041
Fetal Bovine Serum GIBCO Cat# 16000044
Tamoxifen (TMX) Sigma-Aldrich Cat# T5648
Cardiotoxin (CTX) Sigma-Aldrich Cat# 217503
BaCl2 Sigma-Aldrich Cat#B-0750
2-methylbutane Sigma-Aldrich Cat# M32631
Bovine Serum Albumin (BSA) Sigma-Aldrich Cat# A2153
Prolong gold antifade mountant with DAPI Life Technologies Cat# P36931
Paraformaldehyde (PFA) Sigma-Aldrich Cat# 158127
Triton X-100 Sigma-Aldrich Cat# X-100
Prolong gold antifade mountant media no DAPI Life Technologies Cat# P10144
TNB-buffer PerkinElmer Cat# FP1020
Bazedoxifine Pfizer Cas# 198481-33-3
Critical Commercial Assays
In Situ Cell Death, Fluorescein Detection Kit Roche Diagnostics Cat# 11684795910
Vectastain ABC kit Vector Laboratories Cat# PK-6100
Tyramide Signal Amplification (TSA) Plus Cyanine 3 kit PerkinElmer Cat# NEL744
SUPERVILO cDNA Synthesis kit ThermoFisher Cat# 11756050
Direct-Zol MicroPrep Kit Zymo Research Labs Cat# R2061
Red-taq Ready Mix Sigma-Adlrich R2523
(Continued on next page)
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GoTaq_ qPCR Master Mix Promega A6001
Quant-iT RiboGreen_ RNA Assay Kit Scientific ThermoFisher R11490
SMARTer Stranded Total RNA-Seq-Pico Mammalian Kit Clontech 635007
Experimental Models: Organisms/Strains
Mouse: C57/BL6 Jackson Laboratories JAX: 000664
Mouse: Pax7-ZsGreen Bosnakovski et al., 2008 N/A
Mouse: B6.Cg-Pax7tm1(cre/ERT2)Gaka/J Jackson Laboratories JAX: 017763
Mouse: B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J Jackson Laboratories JAX: 007909
Mouse: ERaExon3fl/fl Hewitt et al., 2010 N/A
Oligonucleotides
Primer Sequences See Table S1 N/A
Software and Algorithms
Prism 7 GraphPad RRID:SCR_002798
FlowJo 10 FLOWJO, LLC RRID: SCR_008520
SigmaPlot 12.5 Systat Software Inc RRID:SCR_010455
SPSS 24 IBM Corporation RRID:SCR_002865
ImageJ NIH RRID:SCR_003070
ClustVis Metsalu and Vilo, 2015 N/A
Ingenuity Pathway Analysis QIAGEN N/A
Deposited Data
RNA-seq for transcriptome analysis of ZsGreen+ cells from
Pax7+/+Esr1fl/fl;Pax7-ZsGreen and Pax7CreERT2/+; Esr1fl/fl;
Pax7-ZsGreen
In this study GEO: GSE126872LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Dawn
Lowe (lowex017@umn.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Animal experiments in this study were performed in accordance with protocols approved by the Institutional Animal Care and Use
Committee at the University of Minnesota. All experiments were conducted on female mice when they were young adults (3-4 mo
of age). Satellite cells were harvested from C57/BL6 (Purchased from Jackson Laboratories, 000664) and Pax7-ZsGreen mice
that were either control or ovariectomized (bilateral removal of the ovaries) and sacrificed 2, 3.5, or 7 mo post-surgery (n = 5 mice
for each group). ERafl/fl mice were ovariectomized (Ovx) and half received a 0.18 mg 60-day slow-release 17b-estradiol (Ovx+E2)
pellet via trochar implantation (n = 3-4 mice) (Moran et al., 2007). For strength experiments, C57/BL6 mice were ovariectomized
and half received placebo pellets (Ovx+placebo) and half received 0.18 mg 60-day slow-release 17b-estradiol pellets (Ovx+E2)
(n = 6-8 mice). For Bazedoxifine experiments, C57/BL6 mice were ovariectomized and half received placebo pellets (Ovx+placebo)
and half received 1.44 mg Bazedoxifine (Ovx+BZA) pellets (n = 5-6 mice) (Andersson et al. 2016). For transplant experiments, female
Pax7-ZsGreen and Pax7CreERT2/+;R26RtdTomatomice were donors and were age-matched to female C57/BL6 recipient mice (n = 6-15
mice for each experiment); a subset of recipients was ovariectomized. Pax7CreERT2/+; Esr1fl/fl;Pax7-ZsGreen (scERaKO) and
Pax7+/+Esr1fl/fl;Pax7-ZsGreen (scERaWT) were generated in-house. Female scERaWT and scERaKO mice were treated with 2mg
tamoxifen for 5 d consecutively (Keefe et al., 2015; Murphy et al., 2011). Two mo after tamoxifen treatment, mice were used for
satellite cell harvests (n = 6mice) and transplantation (n = 6mice). For all experiments, the estrous cycle was tracked for 3-5 d consec-
utively via vaginal cytology to confirm mice had normal estrous cycles or had ceased cycling for those that were Ovx (Nelson et al.,
1982). Uterine mass was measured at the time of sacrifice as a second verification of successful ovariectomy surgery or estradiol
treatment (Wood et al., 2007). Uterine mass across all experiments for control, Ovx, and Ovx+E2 mice averaged (SEM): 101.7
(5.1), 13.5 (0.7), and 207.9 (27.0) mg, respectively.Cell Reports 28, 368–381.e1–e6, July 9, 2019 e2
Human Participants
Brieflyparticipants were instructed to wear monitors on the right hip during waking hours for seven consecutive days. Moderate to
vigorous intensity physical activity (MVPA) was defined by using tri-axial vector magnitude cut-point over 2690 counts per minute
(cpm) to define the cut-point for at least moderate intensity level. There were small intra-individual differences in wearing times of
the accelerometer (mean wearing time 15.2 ± 0.3 hours/day across 6.8 ± 0.2 days). Thereforethe MVPA time (min/day) was normal-
ized by wearing time to correspond daily 16 hour waking time. The Ethics Committee of the Central Finland Health Care District
approved the ERMA Study in 2014 (K-S shp Dnro U/2014). An informed consent was given by each participant at the laboratory
before any sampling or measurement was done. Altogetherthe study protocol followed good clinical and scientific practice and
the Declaration of Helsinki, 2018Muscle samples from the Estrogenic Regulation of Muscle Apoptosis (ERMA) Study were analyzed
for satellite cells (n = 5 women). The ERMA study is a population-based longitudinal cohort study comprised of women 47 to 55 years
of age living in the city of Jyväskylä and the neighboring municipalities in Finland (Kovanen et al., 2018). Systemic follicle stimulating
hormone (FSH) and 17b-estradiol levels were immunoassayed by IMMULITE 2000 XPi System (Siemens Healthcare Diagnostics,
UK) from the fasting blood samples taken from the antecubital vein in a supine position between 7:00 and 10:00 AM. Participants
were assigned to menopausal groups using these hormone results, along with information from menstrual cycle diaries, following
guidelines established by Stages of Reproductive Aging Workshop (STRAW+10; Harlow et al., 2012). Percentage of body fat and
lean body mass was assessed by a multifrequency bioelectrical impedance analyzer (InBodyTM 720; Biospace, Seoul, Korea) after
overnight fasting with the participant wearing only undergarments. Physical activity was assessed with ActiGraph accelerometers
(Pensacola, Florida, USA) as in Laakkonen et al. (2017). Briefly, participants were instructed to wear monitors on the right hip during
waking hours for seven consecutive days. Moderate to vigorous intensity physical activity (MVPA) was defined by using tri-axial
vector magnitude cut-point over 2690 counts per minute (cpm) to define the cut-point for at least moderate intensity level. There
were small intra-individual differences in wearing times of the accelerometer (mean wearing time 15.2 ± 0.3 hours/day across
6.8 ± 0.2 days). Therefore, the MVPA time (min/day) was normalized by wearing time to correspond daily 16 hour waking time.
The Ethics Committee of the Central Finland Health Care District approved the ERMA Study in 2014 (K-S shp Dnro U/2014). An
informed consent was given by each participant at the laboratory before any sampling or measurement was done. Altogether, the
study protocol followed good clinical and scientific practice and the Declaration of Helsinki.
METHODS DETAILS
Mouse Satellite Cell Isolation
Isolation of satellite cells from single skeletal muscles (e.g., gastrocnemius) was performed as described previously (Arpke and Kyba,
2016). Muscles were carefully dissected and chopped in parallel with muscle fibers using razor blade and forceps to separate the
fibers. Muscles were incubated shaking for 75min in 0.2% collagenase type II (17101-015, GIBCO, Grand Island, NY) in high glucose
Dulbecco’s modified Eagle’s medium (DMEM) without phenol red containing 4.00mM L-glutamine, 4,500mg/L glucose, and sodium
pyruvate (SH30284.01, Hyclone, Logan, UT) supplemented with 1% Pen/Strep (15140122, GIBCO) at 37C. Samples were washed
with Rinsing Solution (F-10+), Ham’s/F-10 medium (SH30025.01, HyClone) supplemented with 10%Horse serum, 1%HEPES buffer
solution (15630080, GIBCO) and 1% Pen/Strep (GIBCO) and centrifuged at 1500 rpm x 5min at 4C. Samples were washed and
centrifuged a second time. Samples were pulled into a sheared Pasteur pipette, centrifuged and washed again. Following aspiration,
samples were resuspended in F-10+ with collagenase collagenase type II and dispase (17105-041, GIBCO), vortexed and incubated
shaking at 37C for 30 min. Samples were vortexed again, drawn and released into a 3 mL syringe with 16-gauge needle four times
then with an 18-gauge needle four times and passed through a 40-mm cell strainer (Falcon, Hanover Park, IL). 3 mL of F-10+ was
added to each sample and centrifuged at 1500 rpm x 5min 4C. Following aspiration, samples were resuspended in FACS staining
medium (2% FBS in PBS). Bulk isolation (hindlimb muscles excluding soleus, triceps muscles, and psoas muscles) of satellite cells
was performed similarly and as described previously (Arpke et al., 2013).
FACS Analysis and Cell Sorting
Muscle samples were stained using an antibody mixture of PE-Cy7 rat anti-mouse CD31 (clone 390), PE-Cy7 rat anti-mouse CD45
(clone 30-F11), Biotin rat anti-mouse CD106 (clone 429(MVCAM.A)) and PE Streptavidin from BD Biosciences (San Diego, CA); and
Itga7 647 (clone R2F2) from AbLab (Vancouver, B.C., Canada). Antibody cocktail was added to samples and incubated on ice for
30 min. Samples were washed and resuspended with FACS staining media containing propidium iodide for FACS analysis on the
FACSAriaII SORP (BD Biosciences, San Diego, CA). Total satellite cells (lineage negative; VCAM,alpha7 double positive cells or
ZsGreen+) (Figures S1A andS1B) were analyzedwhile draining the entire sample from each skeletal muscle sample. For transplanted
tibialis anterior (TA) muscles, the number of donor (ZsGreen + or tdTOM+) satellite cells were examined as previously described
(Arpke et al., 2013).
Barium Chloride Injury and In Vivo Muscle Torque Measurement
As previously described (Baltgalvis et al., 2009; Baumann et al., 2014; Lowe et al., 1995), contractile function of the left anterior crural
muscles was measured in vivo immediately before the injuries, as well as 7, 14, and 21 days after each injury. Briefly, anesthetized
mice (1.25% isoflurane and 125 mL O2 per minute) were placed on a temperature-controlled platform to maintain core bodye3 Cell Reports 28, 368–381.e1–e6, July 9, 2019
temperature between 35 and 37C. The left knee was clamped and the left foot was secured to an aluminum ‘‘shoe’’ that is attached
to the shaft of an Aurora Scientific 300B servomotor (Aurora Scientific, ON, Canada). Sterilized platinum needle electrodes were
inserted through the skin for stimulation of the left common peroneal nerve. Stimulation voltage and needle electrode placement
were optimized with 5–15 isometric contractions (200 ms train of 0.1 ms pulses at 200 Hz). Two minutes following optimization, con-
tractile function of the anterior crural muscles was assessed by measuring isometric torque as a function of stimulation frequency
(20–300 Hz), with the highest recorded torque defined asmaximal isometric torque. Following pre-injury and 21 day torque measure-
ments, barium chloride (1.2% in sterile demineralized water) (Ricca Chemical Company, Arlington, TX) was injected into the tibialis
anterior muscle of each mouse with a Hamilton syringe similar to Murphy et al. (2014). Functional torque measurements were
performed on the same groups of mice at each time-point post-injury, and expressed relative to pre-injury maximal isometric torque.
Cardiotoxin Injury and Transplantation
Transplant recipient mice were anesthetized with 150 mg/kg ketamine plus 10mg/kg xylazine and both hind limbs were subjected to
a 900 cGy dose of irradiation using an RS 2000 Biological Research Irradiator (Rad Source Technologies, Inc., Suwanee, GA). Lead
shields limited exposure to the hind limbs only. 24 h following irradiation, 15 mL of cardiotoxin (10 mM in PBS, Sigma-Aldrich, Saint
Louis, MO) was injected into both TA muscles of each mouse with a Hamilton syringe. 24 h following cardiotoxin injection, 600
ZsGreen+ cells were resuspended into 10 mL of sterile saline and injected into both TA’s. Both TA’s were harvested 1 mo post-trans-
plantation and prepared for FACS analysis as described above. When tdTom+ cells were transplanted, one TA was harvested and
prepared for FACS analysis and the contralateral TA was harvested and prepared for sectioning and staining.
Immunofluorescence Microscopy in Mouse Samples
TA muscles were removed and placed in OCT compound, frozen in 2-methylbutane (Sigma-Aldrich) cooled by liquid nitrogen and
stored at80C until use. For visualization of satellite cells and apoptotic cells in skeletal muscle, Pax7 and terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) staining was performed on 7 mM cryosections (CM 1850, Leica Microsystems, Buffalo
Grove, IL). TUNEL was detected using In Situ Cell Death, Fluorescein Detection Kit according to manufacturer’s instructions
(11684795910, Roche Diagnostics, Mannheim, Germany). Following TUNEL, Pax7 staining was completed as previously reported
(Keefe et al., 2015; Murphy et al., 2011). In brief, slides were incubated in citrate buffer for 10 min and then antigen retrieval was
performed by microwaving at 20 s intervals for a total of 3 min in citrate buffer. Slides were washed two times in 1x PBS for 2 min
each and blocked in 3% bovine serum albumin (BSA) for 1 h at room temperature. Slides were incubated with anti-pax7 mouse
IgG1 primary antibody (PAX7, Developmental Hybridoma Bank at Iowa University, 1:20 in 3% BSA) overnight at 4C. Slides were
incubated with goat anti-mouse biotin-conjugated secondary antibody (115-065-205, Jackson Immuno Research Laboratories
Inc, West Grove, PA, 1:1000 in 3% BSA) for 1 h at room temperature. Visualization of the primary antibody was performed using
the Vectastain ABC kit (PK-6100, Vector Laboratories, Burlingame, CA) and Tyramide Signal Amplification (TSA) Plus Cyanine
3 kit (NEL744, PerkinElmer, Waltham, MA, 1:50 in diluent buffer). Slides were washed again and then prolong gold antifade mountant
with DAPI (P36931, Life technologies, Grand Island, NY) was applied and coverslip added.
For determination of the cross-sectional area of the TA muscle and to determine the myofiber border, adjacent 7 mm sections of
eachmouse sample were cryo-sectioned. Samples were fixed in 4%PFA for 10 min, washed with 1x PBS and blocked with 3%BSA
in 1x PBS for 60 min at room temperature. Sections were incubated overnight at 4C with primary antibody anti-laminin (L9393;
Sigma-Aldrich, 1:250) diluted in 1% BSA in 1x PBS. Slides were washed with 1x PBS and secondary antibody Alexa 488 goat
anti-rabbit (A11034; Life Technologies, 1:500) was applied for 1 h at room temperature. Slides were washed and then mounted
with Prolong Gold Anti-fade mountant media (Life Technologies).
For visualization of fiber engraftment following transplantation, 10 mM sections of TA muscles were cryosectioned. Samples were
fixed in 2%paraformaldehyde (PFA) for 5min, washedwith 0.01% triton in 1x PBS, permeabilized with 0.2% triton for 5min, and then
blocked with 1% BSA in wash buffer for 30 min at room temperature. Sections were incubated overnight at 4C with primary anti-
bodies diluted in 1% BSA in wash buffer simultaneously; rabbit polyclonal anti-RFP (600-401-379, Rockland Immunochemicals
Inc, Pottstown, PA, 1:200) and mouse monoclonal anti-laminin (Clone LAM-89; Sigma-Aldrich, 1:250). Slides were washed with
wash buffer and secondary antibodies were applied for 1 h at room temperature simultaneously, Alexa 555 goat anti-mouse and
Alexa 480 goat anti-rabbit IgG (A-21422 and A-11034, 1:500; Life Technologies). Slides were washed and thenmounted with prolong
gold anti-fade mountant media (P10144, Life Technologies).
Immunofluorescence Microscopy in Human Samples
Needle muscle biopsies were obtained under local anesthesia from vastus lateralis of five women when they were perimenopausal
and then again after being classified as postmenopausal. Visible connective, adipose tissue and blood was removed before the
biopsy sample was embedded in Tissue Tek compound and frozen in 2-methylbutane (Sigma-Aldrich) cooled in liquid nitrogen
and stored at 150C until use. Pax7 positive cells were identified on 10 mm cryosections (CM 3000, Leica Instruments). In brief,
slides were incubated in citrate buffer for 10 min and then antigen retrieval was performed by microwaving for 4 min in citrate buffer.
Slides cooled for 5min andwerewashedwith 1x PBS. Blocking was done in 2%TNB-buffer (Blocking reagent, FP1020, PerkinElmer)
for 1 h at room temperature. Slides were incubated with anti-pax7 mouse IgG1 primary antibody (PAX7, Developmental Hybridoma
Bank at Iowa University, 1:25 in 2% TNB) overnight at 4C. Slides were incubated with goat anti-mouse biotin-conjugated secondaryCell Reports 28, 368–381.e1–e6, July 9, 2019 e4
antibody (Jackson Immuno Research Laboratories Inc, 1:1000 in 2% TNB) for 1 h at room temperature. Visualization of the primary
antibody was performed using the Vectastain ABC kit (Vector Laboratories) and Tyramide Signal Amplification (TSA) Plus Cyanine
3 kit (PerkinElmer, 1:50 in diluent buffer). Slides were washed again and then Prolong Gold Antifade mountant with DAPI (Life tech-
nologies) was applied.
For determination of the cross-sectional area of myofibers, a serial 10 mmsection of each biopsy was analyzed. To do this, sections
were fixed in 4% PFA for 10 min, washed with 1x PBS and blocked with 3%BSA in 1x PBS for 60 min at room temperature. Sections
were incubated overnight at 4C with rabbit anti-laminin antibody (Sigma-Aldrich, 1:250) diluted in 1% BSA in 1x PBS. Slides were
washed with 1x PBS and secondary antibody Alexa 488 goat anti-rabbit was applied for 1 h at room temperature (Life Technologies,
1:500). Slides were washed and then mounted with Prolong Gold Anti-fade mountant media (Life Technologies).
Image Processing and Analysis
All images were processed and analyzed in a blinded manner with samples being de-identified as to treatment or group. Mouse
muscle samples were examined and imaged using a Leica DM5500B microscope (Leica Microsystems) at 5x-20x magnification.
Images were stitched using the automated tile-scan tool to construct an image of the entire cross-section of the TA muscle. Muscle
cross-sectional area (CSA) in millimeters squared was measured by tracing the muscle section border, stained with laminin, in
ImageJ. Satellite cells were identified by DAPI+ and Pax7+ cell residing along the myofiber border. Myonuclei undergoing apoptosis
were identified as DAPI+ and TUNEL+ cells that were within the myofiber. Satellite cells undergoing apoptosis were identified as
Pax7+, TUNEL+ and DAPI+ residing along the myofiber border. DAPI+ Pax7+ TUNEL+ cells were normalized to muscle cross-
sectional area and percent of cells in each cross-section relative to total number ofmyofibers. For transplantation experiments, donor
cells were quantified by counting RFP+ (Red) fibers using the ImageJ software package (NIH, Bethesda, MD, USA).
Human muscle samples were examined and imaged using a Zeiss LSM 700 confocal microscope (Carl Zeiss MicroImaging, Jena,
Germany) at 10x magnification. Images were stitched using ImageJ software package. The number and cross-sectional area of
myofibers per muscle were counted and measured using laminin staining to delineate each myofiber border in serial sections. Sat-
ellite cells were identified as DAPI+ and Pax7+ cell residing along the myofiber border. The percent of Pax7+ cells are expressed
relative to myofibers counted in each biopsy.
RNA-seq Preparation
RNA from freshly FACS-isolated satellite cells (70,000 – 200,000 satellite cells per mouse) was isolated using direct-Zol MicroPrep kit
(R2061, Zymo Research, Irvine, CA). On-column DNase digestion was performed according to manufacturer protocols to prevent
genomic DNA contamination. Total RNA was quantified using a fluorimetric RiboGreen assay. RNA and library preparation integrity
were verified using a 2100 BioAnalyzer system (Agilent,Wokingham, UK), generating an RNA integrity number (RIN). All samples were
at least 250 pg total RNA and RIN values of 3. Libraries were prepared using the Smarter Stranded Total RNA_Seq Kit (Clontech,
Mountain View, CA, USA) following the pico input protocol using n = 3 for biological replicates. In summary, between 250 pg –
10 ng of total RNA was fragmented and then reverse transcribed into cDNA using random primers. The Template Switching Oligo
was incorporated during cDNA synthesis and allowed for full length cDNA synthesis and strand specificity to be retained. Illumina
sequencing adapters and barcodes were then added to the cDNA via limited PCR amplification. Next, mammalian ribosomal
cDNAwas enzymatically cleaved. Uncleaved fragments were PCR enriched 12-16 cycles. Final library size distribution was validated
using capillary electrophoresis and quantified using fluorimetry (PicoGreen). Indexed libraries were then normalized and pooled for
sequencing. Illumina libraries were hybridized to a paired end flow cell and individual fragments were clonally amplified by bridge
amplification on the Illumina cBot (Illumina, Saffron Walden, UK). Once clustering was complete, the flow cell was loaded on the
HiSeq 2500 and sequenced using Illumina’s SBS chemistry. Upon completion of read 1, an 8 base pair index read for Index 1
was performed. The Index 1 product was then removed and the template re-anneals to the flow cell surface. The run proceeds
with 7 chemistry-only cycles, followed by an 8 base pair index read to read Index 2. Finally, the library fragments were resynthesized
in the reverse direction and sequenced from the opposite end of the read 1 fragment thus producing the template for paired end
read 2. Base call (.bcl) files for each cycle of sequencing are generated by Illumina Real Time Analysis software. The base call files
and run folders are then exported to servers maintained at the Minnesota Supercomputing Institute. Primary analysis and de-multi-
plexing are performed using Illumina’s CASAVA software 1.8.2.
RNA-seq analysis
RNA-seq reads were aligned to Mus musculus reference transcriptome (GRCm38/mm10) using Kallisto (v0.44.0) quant (Bray et al.,
2016), and the R package tximport (v1.10.0) was used to convert the output to Transcript Per Million (TPM) values (Soneson et al.,
2015). Genes with a threshold of TPM > 5 were considered to be appreciably expressed with high confidence and used for
further analysis. Principal component analysis (PCA) and hierarchical clustering were performed on 300 genes (around 10% of genes
TPM > 5) with the highest variance in TPM value across all samples, using ClustVis software with default settings (Metsalu and Vilo,
2015). To identify molecular and celluar functions in which appreciably expressing genes were enriched, downstream function
enrichment analysis was conductedwith Ingenuity Pathway Analysis software (IPA; Ingenuity Systems, RedwoodCity, CA). Heatmap
of differentially expressed (scERaWT versus scERaKO, fold change > 2, p < 0.05) and apoptosis-associated genes was generated
using the R package heatmap (v1.0.12).e5 Cell Reports 28, 368–381.e1–e6, July 9, 2019
qRT-PCR
RNA from freshly FACS-isolated satellite cells was isolated using direct-Zol MicroPrep kit according to manufacturer’s instructions.
cDNAwas synthesized from10ngRNAaccording to directions in SUPERVILOcDNASynthesis Kit (11756050, ThermoFisher,Waltham,
MA). Relative quantitation of the ERa (Esr1), p53, p38, Beclin-1 (Becn1) caspase-3 (Casp3), H19, 24-Dehydrocholesterol
reductase (DhCR24), SMAC (DIABLO), and TNF transcripts were determined using TaqMan probes (ThermoFisher) for ESR1
(Mm00433149_m1), Trp53 (Mm01731290_g1), Mapk14 (Mm01301009_m1), BECN1 (Mm00477631_m1), CASP3 (Mm01195085_m1),
H19 (Mm01156721_g1), DhCR24 (Mm00519071_m1), DIABLO (Mm01194441_m1), TNF (Mm00443258_m1), and house-keeping
gene gapdh (Mm99999915_g1).
Statistical Analysis
Data are presented as means ± SE. Two-way analysis of variance (ANOVA) were used to determine differences among time and
treatment. Significant main effects of two-way ANOVA are indicated above the bars in the figure. If an interaction was significant,
Holm-Sidak post hoc tests were used. Other mouse data were analyzed with independent t- tests for determining differences
between groups. Human data were analyzed with Wilcoxon Signed Rank test and independent t- tests to determine differences
between peri- and post-menopause. Analyses were conducted using SigmaPlot (version 12.5, Systat Software, Inc) for mouse
data and using SPSS (version 24, IBM Corporation) for human data.
DATA AND CODE AVAILABILITY
The accession numbers for the RNA-seq data reported in this paper are shown in the Key Resources table (GEO: GSE126872 ;
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE126872)Cell Reports 28, 368–381.e1–e6, July 9, 2019 e6
